0001209191-21-016027.txt : 20210302
0001209191-21-016027.hdr.sgml : 20210302
20210302163626
ACCESSION NUMBER: 0001209191-21-016027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hingtgen Tim
CENTRAL INDEX KEY: 0001598637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 21704289
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-01
0
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001598637
Hingtgen Tim
4000 MERIDIAN BOULEVARD
FRANKLIN
TN
37067
1
1
0
0
CEO
Common Stock
2021-03-01
4
M
0
150000
0.00
A
516131
D
Common Stock
2021-03-01
4
A
0
100000
0.00
A
616131
D
Common Stock
2021-03-02
4
F
0
86081
8.81
D
530050
D
Performance Based Restricted
0.00
2021-03-01
4
M
0
75000
0.00
D
Common Stock
75000
0
D
Performance Based Restricted
0.00
2021-03-01
4
A
0
200000
0.00
A
Common Stock
200000
200000
D
Stock Options (Right to Buy)
8.81
2021-03-01
4
A
0
100000
0.00
A
2022-03-01
2031-02-28
Common Stock
100000
100000
D
Performance Based Restricted
0.00
Common Stock
112500
112500
D
Performance Based Restricted
0.00
Common Stock
150000
150000
D
Stock Options (Right to Buy)
17.49
2013-02-16
2022-02-15
Common Stock
334
334
D
Stock Options (Right to Buy)
4.99
2020-03-01
2029-02-28
Common Stock
56250
56250
D
Stock Options (Right to Buy)
4.93
2021-03-01
2030-02-28
Common Stock
75000
75000
D
Stock Options (Right to Buy)
4.93
2021-03-01
2030-02-28
Common Stock
200000
200000
D
The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018.
The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.
Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.
Christopher G. Cobb, Attorney in Fact for Tim Hingtgen
2021-03-02